Missouri is positioned to launch a statewide prescription drug monitoring program at last, but clinical professionals will not have access to patient-specific data to potentially prevent or treat addiction disorders.
July 26, 2017 | Ron Manderscheid, PhD, Exec Dir, NACBHDD and NARMH
The clock is ticking on the 20 hour Senate “debate” on healthcare reform, and nothing good will emerge from this process. Hence, the desired outcome that we must embrace is that no agreement be reached.
July 18, 2017 | Ron Manderscheid, PhD, Exec Dir, NACBHDD and NARMH
A handful of Republican senators stood up for the American people and derailed health reform legislation proposed by the GOP leadership that can only be characterized as possibly the worst legislation in more than a century.
Endo Pharmaceuticals on Thursday agreed to remove its long-acting Opana ER pain drug from the market, about a month after FDA requested that the company stop selling the product because of the growing incidents of misuse.